RODNEY HALTOM: Open Payments
NPI 1073668943 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,103 in 36 payments from 15 companies in 2025. Trend: 2023 $1,067 · 2024 $1,237 · 2025 $1,103
Food & beverage: $1,080Education: $23
| Company | Payments | Amount |
|---|---|---|
| Syndax Pharmaceuticals, Inc. | 6 | $233 |
| GlaxoSmithKline, LLC. | 5 | $130 |
| SOBI, INC | 4 | $117 |
| Astellas Pharma US Inc | 3 | $94 |
| PharmaEssentia USA Corporation | 3 | $90 |
| AstraZeneca Pharmaceuticals LP | 3 | $85 |
| ABBVIE INC. | 2 | $66 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $58 |
| Novartis Pharmaceuticals Corporation | 2 | $55 |
| TAIHO ONCOLOGY, INC. | 1 | $35 |
Products named: OJJAARA, Vonjo, Cresemba, BESREMI, EPKINLY, CALQUENCE, ICLUSIG, SCEMBLIX.
Industry payments across TX — which companies pay providers there.
